Pfizer in $41.5 million settlement with Texas over ADHD drug for children
19.11.2025
(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program over alleged quality control lapses in a medicine to treat attention deficit hyperactivity disorder in children.